David J Pocalyko

Title: David J Pocalyko: Innovator in Cancer Research

Introduction

David J Pocalyko is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of cancer research, particularly in the development of neoantigens for ovarian and prostate cancers. With a total of 3 patents, his work is paving the way for innovative treatments in oncology.

Latest Patents

David's latest patents include "Neoantigens expressed in ovarian cancer and their uses" and "Prostate neoantigens and their uses." The first patent focuses on ovarian cancer neoantigens, detailing polynucleotides encoding them, vectors, host cells, recombinant virus particles, and vaccines that incorporate these neoantigens. It also covers proteinaceous molecules that bind to the ovarian cancer neoantigens and methods for their production and application. The second patent addresses prostate neoantigens, similarly outlining the components and methods related to their use in vaccines and treatments.

Career Highlights

David J Pocalyko is currently associated with Janssen Biotech, Inc., where he continues to advance his research in cancer immunotherapy. His work is instrumental in developing targeted therapies that could significantly improve patient outcomes.

Collaborations

David collaborates with esteemed colleagues such as Vipul Bhargava and Vinod Krishna, contributing to a dynamic research environment focused on innovative cancer treatments.

Conclusion

David J Pocalyko's contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His work in neoantigens represents a promising frontier in the fight against cancer.